SCREEN Act of 2013

To amend title XVIII of the Social Security Act to improve coverage for colorectal screening tests under Medicare, and for other purposes. 1. Short title; table of contents (a) Short title This Act may be cited as the Supporting Colorectal Examination and Education Now Act of 2013 SCREEN Act of 2013 (b) Table of contents The table of contents of this Act is as follows: Sec. 1. Short title; table of contents. Sec. 2. Findings. Sec. 3. Temporary increase in payment rate for certain cancer screening tests. Sec. 4. Waiving Medicare cost-sharing for colorectal cancer screening with therapeutic effect. Sec. 5. Medicare coverage for an office visit or consultation prior to a qualifying screening colonoscopy. Sec. 6. Budget neutrality. 2. Findings Congress finds the following: (1) Colon cancer is the third most common cause of cancer-related deaths and the second most common cancer for both men and women. (2) According to the American Cancer Society, over 50,000 people will die this year from colon cancer. (3) Colorectal cancer is highly treatable with appropriate screening. According to the American Cancer Society (2010 Facts & Figures), the 5-year survival rate is 90 percent for those individuals who are diagnosed at an early stage of the cancer. However, less than 40 percent of colon cancer cases are diagnosed at an early stage. (4) The Centers for Disease Control and Prevention recently estimated that approximately 2,000 deaths could be avoided if colonoscopy screening rates rose by just 10 percent. (5) Colonoscopies allow for simultaneous colorectal cancer screenings and detection and the removal of precancerous polyps, thus preventing cancer from developing. (6) The U.S. Preventive Services Task Force provides an A (7) The Centers for Disease Control and Prevention’s colorectal cancer control program has set a target of screening 80 percent of eligible adults in certain States by 2014. The American Cancer Society and other patient advocacy groups have a target rate of 75 percent. (8) Only between 52 and 58 percent of Medicare beneficiaries have had any colorectal cancer screening test, despite Medicare coverage for such tests. (9) Only 49.3 percent of Medicare beneficiaries who are 50 to 80 years old receive colorectal cancer screenings within recommended intervals. (10) The Centers for Medicare & Medicaid Services notes that there is clearly an opportunity to improve colorectal cancer screening rates in the Medicare population (11) A January 2011 study by the Colon Cancer Alliance concludes that most Americans over the age of 50— (A) wish a health care provider was able to sit down with them to discuss a colonoscopy before undergoing the test; and (B) forgo a colonoscopy due to fear of the procedure. (12) In February 2010, the National Institutes of Health hosted a conference on colorectal cancer screening and cited patient awareness and fears as barriers to increasing colorectal cancer screening rates. (13) According to the Medicare Payment Advisory Commission, colonoscopy is one of the most common procedures performed in the ambulatory surgical centers (ASCs) and the decline in payment rate for the highest volume procedures is especially a strong concern for ASCs that focus on gastroenterology (14) An Institute of Medicine study on colorectal cancer screening cited the inadequate reimbursement for preventive care services as one of the constraints limiting colorectal cancer screening rates. (15) Colorectal cancer screening by colonoscopy has been demonstrated to reduce Medicare costs over the long-term. 3. Temporary increase in payment rate for certain cancer screening tests (a) In general With respect to a qualifying cancer screening test furnished during the 5-year period beginning on January 1, 2014, by a qualifying provider, the amount otherwise payable under section 1833 or section 1848 of the Social Security Act ( 42 U.S.C. 1395l (b) Qualifying cancer screening test (1) In general For purposes of this section, subject to paragraph (2), the term qualifying cancer screening test (2) Termination when high utilization rate reached If the Secretary of Health and Human Services determines that a cancer screening test described in paragraph (1) has a utilization rate of at least 75 percent of the Medicare beneficiaries for whom such screening has such a recommendation, effective as of the first day of the year after the year in which such determination is made, the cancer screening test shall not be a qualifying cancer screening test. (c) Qualifying provider defined For purposes of this section, the term qualifying provider (1) that is eligible for payment for such test under section 1833 or section 1848 of the Social Security Act ( 42 U.S.C. 1395l (2) that— (A) participates in a nationally recognized quality improvement registry with respect to such test; and (B) demonstrates, to the satisfaction of the Secretary, based on the information in such registry, that the tests were provided by such individual or entity in accordance with accepted outcomes-based quality measures. 4. Waiving Medicare cost-sharing for colorectal cancer screening with therapeutic effect (a) In general Section 1833(a)(1)(Y) of the Social Security Act ( 42 U.S.C. 1395l(a)(1)(Y) , including tests and procedures described in the last sentence of subsection (b), section 1861(ddd)(3) (b) Effective Date The amendment made by this section shall apply to tests and procedures performed on or after January 1, 2014. 5. Medicare coverage for an office visit or consultation prior to a qualifying screening colonoscopy (a) Coverage Section 1861(s)(2) of the Social Security Act ( 42 U.S.C. 1395x(s)(2) (1) in subparagraph (EE), by striking and (2) in subparagraph (FF), by inserting and (3) by adding at the end the following new subparagraph: (GG) prior to a colorectal cancer screening test consisting of a screening colonoscopy or in conjunction with an individual’s decision regarding the performance of such a test on the individual, an outpatient office visit or consultation for the purpose of beneficiary education, assuring selection of the proper screening test, and securing information relating to the procedure and the sedation of the individual; . (b) Payment (1) In general Section 1833(a)(1) of the Social Security Act (42 U.S.C. 1395l(a)(1)) is amended— (A) by striking and (Z) (B) by inserting before the semicolon at the end the following: , and (AA) with respect to an outpatient office visit or consultation under section 1861(s)(2)(GG), the amounts paid shall be 80 percent of the lesser of the actual charge or the amount established under section 1848 (2) Payment under physician fee schedule Section 1848(j)(3) of the Social Security Act ( 42 U.S.C. 1395w–4(j)(3) (2)(GG), (2)(FF) (including administration of the health risk assessment), (3) Requirement for establishment of payment amount under physician fee schedule Section 1834(d) of the Social Security Act (42 U.S.C. 1395m(d)) is amended by adding at the end the following new paragraph: (4) Payment for outpatient office visit or consultation prior to screening colonoscopy With respect to an outpatient office visit or consultation under section 1861(s)(2)(GG), payment under section 1848 shall be consistent with the payment amounts for CPT codes 99201, 99202, 99203, 99204, 99211, 99212, 99213, 99214, and 99215 (as in effect as of the date of the enactment of this paragraph or any successors to such codes). . (c) Effective Date The amendments made by this section shall apply to items and services furnished on or after January 1, 2014. 6. Budget neutrality (a) Adjustment of physician fee schedule conversion factor The Secretary of Health and Human Services (in this section referred to as the Secretary 42 U.S.C. 1395w–4 (b) Adjustment of HOPD conversion factor The Secretary shall reduce the conversion factor established under paragraph (3)(C) of section 1833(t) of the Social Security Act ( 42 U.S.C. 1395l(t) (c) Determinations relating to expenditures For purposes of this section, before the beginning of each year (beginning with 2014) at the time conversion factors described in subsection (a) and (b) are established for the year, the Secretary shall determine— (1) the amount of the gross additional expenditures under title XVIII of the Social Security Act (42 U.S.C. 1395 et seq.) estimated to result from the implementation of sections 3, 4, and 5 for items and services furnished during the year; (2) the amount of any offsetting reductions in expenditures under such title (such as reductions in payments for inpatient hospital services) for such year attributable to the implementation of such sections; (3) the amount (if any) by which the amount of the gross additional expenditures determined under paragraph (1) for the year exceeds the amount of offsetting reductions determined under paragraph (2) for the year; (4) of the gross additional expenditures determined under paragraph (1) for the year that are attributable to expenditures under sections 1848 and 1833(t) of such Act ( 42 U.S.C. 1395w–4 (5) with respect to section 1848 and section 1833(t) of such Act ( 42 U.S.C. 1395w–4 (A) the amount of the net additional expenditures for the year determined under paragraph (3); and (B) the ratio determined under paragraph (4) attributable to the respective section.

Summary: Supporting Colorectal Examination and Education Now Act of 2013 or SCREEN Act of 2013 - Increases Medicare payments to qualifying Medicare providers by 10% for cancer screening tests recommended by the U.S. Preventive Services Task Force. Terminates the increase for a test when it reaches a 75% utilization rate for beneficiaries for whom such screening is recommended. Makes a Medicare provider eligible for such increased payment only if the provider: (1) participates in a nationally recognized quality improvement registry with respect to such test, and (2) demonstrates that the tests were provided in accordance with accepted outcomes-based quality measures. Amends title XVIII (Medicare) of the Social Security Act to waive cost-sharing for colorectal cancer screening tests. Extends Medicare coverage to include an outpatient office visit or consultation prior to a colorectal cancer test consisting of a screening colonoscopy, or in conjunction with an individual's decision regarding the performance of such a test on the individual, for the purpose of beneficiary education, assuring selection of the proper screening test, and securing information relating to the procedure and the sedation of the individual. Requires the Secretary of Health and Human Services (HHS) to reduce the conversion factors for purposes of payment to physicians and hospital outpatient departments under Medicare to offset the additional expenditures under this Act.